Angela Schulz
0000-0001-9156-4861
3 papers found
Refreshing results…
Development of the “Hamburg Best Practice Guidelines for ICV−Enzyme Replacement therapy (ERT) in CLN2 Disease” Based on 6 Years Treatment Experience in 48 Patients
Cerliponase alfa for the treatment of atypical phenotypes of CLN2 disease: A retrospective case series
Volumetric Description of Brain Atrophy in Neuronal Ceroid Lipofuscinosis 2: Supratentorial Gray Matter Shows Uniform Disease Progression
Missing publications? Search for publications with a matching author name.